Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dyne Therapeutics
Biotech
BMS vet answers Foghorn’s call for CBO—Chutes & Ladders
BMS vet answers Foghorn’s call for CBO. Orbital charges up with former Spark CEO. CellCentric secures first CDO.
Darren Incorvaia
,
Zoey Becker
,
Gabrielle Masson
Sep 6, 2024 8:30am
Dyne shakes up C-suite after hazy DMD data drop
Sep 3, 2024 11:49am
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
BIO CEO out the door—Chutes & Ladders
Oct 14, 2022 9:30am
Ascidian Therapeutics rises from ATP's ocean floor with $50M
Oct 12, 2022 11:34am
Novartis R&D chief Jay Bradner departs—Chutes & Ladders
Sep 2, 2022 9:30am